|
|
| Countries covered: Spain The birth origins of the Pharmaceutical Industry can be traced back to more humble antecedents than just chemistry labs. The earliest incidents of recognition of the antiseptic properties of the dyestuffs is around the late 19th century. The invention of penicillin can yet be recognized as a major milestone for the emergent industry which firmly consolidated its R&D efforts in the 1950’s. Further in the 1960’s the patent regulation support gave a further impetus to the industry in new discoveries and relaxed controls on clinical development with the booming spend on healthcare as economies boomed globally. The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D programs and drugs which help companies maximize penetration of markets and garner increased revenues with intercontinental treatment demand of patients being serviced from often one or two mega research centers in the continent. The pharmaceutical industry is under mounting scrutiny because of rapidly increasing expenditures for drugs worldwide. Drug expenditures are now the fastest-growing component of health care costs, increasing at the rate of about 15 percent per year. They account for about eight percent of health care spending, and at their current rate of increase, they will soon surpass spending for physicians' services and, for many health care organizations, the costs of hospitalization. Aruvian’s R’search brings you a complete analysis of the Pharmaceutical Industry in Spain. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, offshoring in the pharmaceutical industry, economic trends in the industry, competition in the industry, and the key players in the pharmaceutical industry in Spain – complete with a SWOT analysis of the leading companies in the market. |
More Spain Prescription Drugs Reports
Spain Pharmaceuticals and Healthcare Report Q2 2012 by
Business Monitor International
BMI View: Companies with significant exposure to debt-ridden European markets will be hard hit bygovernment austerity measures across the region, particularly by pharmaceutical price erosionmechanisms. ...
The Pharmaceutical Market: Spain (pdf/xls) by
Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Pharmaceuticals – Spain – a snapshot (2011) by
Mintel - Snapshots
Pharmaceuticals in Spain by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription ...
Pharmaceuticals in Spain: ISIC 2423 by
Euromonitor International
Euromonitor International's Industrial reports provide a 360 degree view of an industry. TheIndustrial market report offers a comprehensive guide to the size and shape of ...
Spain Pharmaceutical Market Overview - Price cuts set to negatively impact both branded and generics companies by
Datamonitor
Introduction The Spanish prescription pharmaceutical market was valued at $22.1bn in sales in 2009, with an annual growth rate of 6.4% between 2008 and 2009. Key ...
See all reports like this >>
More Spain Reports
D&B Country RiskLine Report: Spain by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Spain by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report Spain January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Spain: Country Profile by
MarketLine
INTRODUCTION This report provides a detailed analysis of Spain, providing an overview of its political, economic and business environment, represented both textually and in graph and ...
2007 Spain Industry & Market Outlook report by
Barnes Reports
The 2007 Spain Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Spain and 500+ minor industries ...
See all reports like this >>
Related Markets
Prescription Drugs Reports
- Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
- Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program
- Chinese Markets for Hepatitis Drugs
- Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion
